0001493152-22-017528.txt : 20220622 0001493152-22-017528.hdr.sgml : 20220622 20220622171624 ACCESSION NUMBER: 0001493152-22-017528 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220615 FILED AS OF DATE: 20220622 DATE AS OF CHANGE: 20220622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Holley Danica CENTRAL INDEX KEY: 0001657320 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52218 FILM NUMBER: 221032904 BUSINESS ADDRESS: BUSINESS PHONE: 2402045378 MAIL ADDRESS: STREET 1: 4800 MONTGOMERY LANE SUITE 450 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERALINK TECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001362703 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202590810 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8000 INNOVATION PARK STREET 2: DR, BATON ROUGE CITY: BATON ROUGE STATE: LA ZIP: 70820 BUSINESS PHONE: 225-578-7555 MAIL ADDRESS: STREET 1: 8000 INNOVATION PARK STREET 2: DR, BATON ROUGE CITY: BATON ROUGE STATE: LA ZIP: 70820 FORMER COMPANY: FORMER CONFORMED NAME: OncBioMune Pharmaceuticals, Inc DATE OF NAME CHANGE: 20150903 FORMER COMPANY: FORMER CONFORMED NAME: QUINT MEDIA INC. DATE OF NAME CHANGE: 20130807 FORMER COMPANY: FORMER CONFORMED NAME: PediatRx Inc. DATE OF NAME CHANGE: 20101230 4 1 ownership.xml X0306 4 2022-06-15 0 0001362703 THERALINK TECHNOLOGIES, INC. THER 0001657320 Holley Danica 9410 BILTMORE DRIVE SILVER SPRING MD 20901 1 0 0 0 8% Convertible Promissory Note 0.0048 2022-06-15 4 J 0 50000 50000 A 2022-06-29 2027-06-01 Common Stock 10504202 50000 D Warrants (right to buy) 0.0048 2022-06-15 4 J 0 2100840 0 A 2022-06-15 2027-06-01 Common Stock 2100840 2100840 D The Reporting Person purchased this promissory note from the corporation. The promissory note may be converted at the Reporting Person's election at any time following amendment to the corporation's articles of incorporation with the Secretary of State of the State of Nevada to increase the corporation's authorized stock to 100,000,000,000. This amendment to the corporation's articles of incorporation is expected to be filed on June 29, 2022. Additionally, the promissory note will automatically convert upon the listing or trading of common stock on a qualified national exchange. Excludes shares issuable at the election of the Reporting Person upon conversion of accrued interest (both past and future) into shares of common stock. Granted to the Reporting Person as warrant coverage in connection with the convertible promissory note reported on this Table II. /s/ Danica Holley 2022-06-22